PNPLA3 and hepatocellular carcinoma: New HCC developed in 11 cases and the 5–year incidence rate of HCC was 3.3% in patients with both PNPLA3 GG/GC and HSD17B13 A/A, which was significantly higher than the rate for those with other SNP profiles (0.6%, p = 0.03).